BriaCell Therapeutics Stock Quote BCTX - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.69

Bid

0.68

Ask

0.69

Volume

2,666,461

0.65 Day's Range 0.708

0.4641 52 Week Range 6.36

Market Cap

12.685M

Previous Close

0.649

Open

0.65

Last Trade

300

0.69

(formt)

Last Trade Time

Financial Volume

$ 1,830,110

VWAP

0.686344

Average Volume (3m)

3,859,404

Shares Outstanding

18,384,661

Dividend Yield

PE Ratio

-9.60

Earnings Per Share (EPS)

-1.1

Revenue

Net Profit

-20.3M

BriaCell Therapeutics Corp. is a clinical stage immuno-oncology company that is developing an entirely new class of targeted immunotherapies to transform cancer care. Bria-IMT(TM), BriaCell's lead candidate, was awarded Fast Track status by FDA and is being evaluated in a pivotal Phase 3 combination... BriaCell Therapeutics Corp. is a clinical stage immuno-oncology company that is developing an entirely new class of targeted immunotherapies to transform cancer care. Bria-IMT(TM), BriaCell's lead candidate, was awarded Fast Track status by FDA and is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC). MBC is breast cancer that has spread to other tissues. Bria-IMT(TM) is a targeted cell-based immunotherapy. Additionally, BriaCell is developing, Bria-OTS(TM), a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical study initially targeting breast cancer, with extension to prostate cancer, and other cancers. Show more

Sector

Aircraft

Industry

Business Services, Nec

Website

www.briacell.com

Headquarters

Vancouver, British Columbia, Can

Founded

2009

BriaCell Therapeutics Corporation is listed in the Aircraft sector of the NASDAQ with ticker BCTX. The last closing price for BriaCell Therapeutics was $0.65. Over the last year, BriaCell Therapeutics shares have traded in a share price range of $ 0.4641 to $ 6.36.

BriaCell Therapeutics currently has 18,384,661 shares outstanding. The market capitalization of BriaCell Therapeutics is $11.93 million. BriaCell Therapeutics has a price to earnings ratio (PE ratio) of -9.60.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.14	25.4545454545	0.55	0.69	0.4641	5112564	0.54631651	CS
4	-0.18	-20.6896551724	0.87	1.96	0.4641	10730540	0.62743862	CS
12	-0.48	-41.0256410256	1.17	1.96	0.4641	3859404	0.63969961	CS
26	-1.96	-73.9622641509	2.65	3.03	0.4641	1853843	0.67428286	CS
52	-4.81	-87.4545454545	5.5	6.36	0.4641	976597	0.8573637	CS
156	-7.4839	-91.5584971678	8.1739	12.47	0.4641	699214	4.71297035	CS
260	-3.55	-83.7264150943	4.24	12.47	0.4641	1049674	5.15585019	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
KAVLKaival Brands Innovations Group Inc	$ 1.33 (129.71%)	182.45M
LASELaser Photonics Corporation	$ 18.8671 (81.24%)	13.54M
TGLTreasure Global Inc	$ 1.18 (73.45%)	139.93M
NVVENuvve Holding Corporation	$ 6.68 (70.41%)	31.34M
UXINUxin Ltd	$ 2.42 (52.68%)	18.24M
ELABElevai Labs Inc	$ 0.10545 (-62.34%)	23.66M
ADTXAditxt Inc	$ 0.262 (-31.52%)	3.17M
FRGTFreight Technologies Inc	$ 0.081 (-28.82%)	26.36M
ANEBAnebulo Pharmaceuticals Inc	$ 2.23 (-27.60%)	113.78k
STSSSharps Technology Inc	$ 0.1722 (-27.06%)	2.27M
XPONExpion360 Inc	$ 0.1144 (34.91%)	432.14M
NVDANVIDIA Corporation	$ 116.26 (0.22%)	206.23M
INTCIntel Corporation	$ 22.56 (3.30%)	184.43M
KAVLKaival Brands Innovations Group Inc	$ 1.33 (129.71%)	182.45M
TGLTreasure Global Inc	$ 1.18 (73.45%)	139.93M